The EDC is live today — see what ships now
All studies
NCT07623252From ClinicalTrials.govRecruiting

Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected

A Multicenter Prospective Diagnostic Accuracy Study of the 2022 International Criteria for Optic Neuritis and an Antibody-Stratified Adjunct in Acute or Subacute Visual Loss When Optic Neuritis Is Suspected in China

  • Optic Neuritis
  • Optic Neuropathy
  • Visual Loss

At a glance

Phase
Phase not stated
Study type
Observational
Sponsor
First Affiliated Hospital of Guangxi Medical University
Enrolment target
500
Started
6 January 2025
Main results due
December 2027
Study sites
9
Registry updated
25 September 2026

Can you take part?

  • No age limit is stated.
  • Open to any sex.
  • You need the condition being studied — healthy volunteers are not accepted.

These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.

Read the full eligibility criteria
Inclusion Criteria:

1. Individuals presenting with a new acute or subacute episode of visual loss or visual dysfunction in one or both eyes, for whom optic neuritis is considered a reasonable differential diagnosis by the treating clinical team at the initial clinical assessment and before final diagnostic adjudication.
2. Symptom onset of the current episode within 90 days before enrollment.

Exclusion Criteria:

1\. The participant has previously been enrolled in this study. Each participant may be enrolled only once.

A history of optic neuritis or recurrent optic neuropathy before the current episode is not an exclusion criterion.

What this study is about

In the sponsor’s own words, from the registry.

Optic neuritis is an important cause of acute or subacute visual loss. In clinical practice, optic neuritis must often be distinguished from other optic neuropathies, retinal diseases, anterior-segment or ocular media disorders, non-organic visual loss, and other mimics. The 2022 International Criteria for Optic Neuritis were developed to standardize the diagnosis of optic neuritis, but their performance in Chinese clinical settings, where aquaporin-4 immunoglobulin G positive and myelin oligodendrocyte glycoprotein immunoglobulin G positive optic neuritis are relatively common, remains uncertain.

This multicenter prospective observational study is enrolling patients with acute or subacute visual loss or visual dysfunction in whom optic neuritis is included in the differential diagnosis. The study is designed to evaluate the diagnostic performance of the 2022 International Criteria for Optic Neuritis alone and with an antibody-stratified adjunct. The index classifications will be compared with an expert-adjudicated reference-standard diagnosis. No experimental treatment is assigned by the study. All diagnostic tests and treatments are determined by the treating clinicians according to routine clinical care. Study data are collected using a structured protocol-defined case report form.

Study sites(9)

  • Guangxi Minzu Hospital

    Nanning, Guangxi, China

    Recruiting

  • The Second Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

    Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China

    Recruiting

  • Guangxi Jingliang Eye Hospital

    Nanning, Guangxi, China

    Recruiting

  • Wuming Hospital of Guangxi Medical University

    Nanning, Guangxi, China

    Recruiting

  • The Second People's Hospital of Qinzhou

    Qinzhou, Guangxi, China

    Recruiting

  • Wuzhou Gongren Hospital

    Wuzhou, Guangxi, China

    Recruiting

  • The First People's Hospital of Yulin

    Yulin, Guangxi, China

    Recruiting

  • Lixiang Eye Hospital of Soochow University

    Suzhou, Jiangsu, China

    Recruiting

Showing 9 of 9 sites. 9 of the 9 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.

Source: ClinicalTrials.gov record NCT07623252. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.

Not the right study?

Answer three questions and see the studies recruiting near you, in plain language.

Find a study for me
Prospective Evaluation of the 2022 Optic Neuritis Criteria When Optic Neuritis Is Suspected | Trialion